You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it.
NO
YES

HIGHLIGHTS

EVENTS

Kedrion scientific symposium at the 2019 PNS Conference in Genoa, Italy

A chance for world Key Opinion Leaders to debate possible new therapies for the treatment of CIPN

read more 

PLASMA & BIOTHERAPIES

First patient enrolled and treated in Kedrion’s CARES10 clinical study

Phase 3 study to assess efficacy, safety and pharmacokinetics of a 10% IVIg in the treatment of adult PID patients

read more 

EVENTS

June 27 and 28 in Trieste (Italy), a two-day event dedicated to hemophilia

Replacement therapy, personalization and access to treatment are the main themes of the congress organized by Kedrion

read more 
  1. PLASMA & BIOTHERAPIES - 27-11-2013

    Distribution of the first recombinant Factor VIII from human cells

    Kedrion to be the distributor in Italy over the next ten years. The indication is the treatment of…

    read more 
  2. CORPORATE - 11-11-2013

    Kedrion and La Kelley Communication for a donation in Pakistan

    500,000 IU of Factor IX shipped to the Pakistan Hemophilia Patients Welfare Society Rawalpindi.

    read more 
  3. CORPORATE - 07-10-2013

    Kedrion donates 1 million IU of FIX to support WHF Humanitarian Aid Program

    The aim is to broaden access to haemophilia treatment regardless of the patients’ geographical location.

    read more 

Pages

For more information please contact: pressoffice@kedrion.com